Companies
Acquired by KnowBe4
Acquired by Apple
Acquired by Capital D
Acquired by Oracle
Acquired by Siemens
Acquired by ERT Inc
IPO: AREC
IPO: ORTX
IPO: FRLN
IPO: ACHL
IPO: MGTX
Acquired by Facebook
IPO: BKNG
Acquired by Anthropic
Explore our investments
-
Frontiers Strategy investments
-
Established2016In collaboration with UCL Business
-
Total investment> $2bnOver $2bn of follow on funding for portfolio
-
Public offerings4 IPOsFour NASDAQ IPOs since 2018
Featured investments
EpilepsyGTx raises $33m Series A to develop single dose gene therapy for focal refractory epilepsy
Humaloop joins Anthropic
Anthropic has hired three cofounders and a number of senior employees from London-based AI startup HumanLoop.
Companies
-
Achilles TherapeuticsBiopharmaceutical company developing precision T cell therapies
Frontiers StrategyIPO -
Apollo Therapeuticsbiopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs Frontiers StrategyGrowth
-
Axovia TherapeuticsGene therapy company developing disease-transformative medicines for ciliopathies Frontiers StrategyEarly Stage
-
Bloomsbury AIEnabling everyone to easily create their own question-answering system Frontiers StrategyExited
-
Bloomsbury GTXBiotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases Frontiers StrategyExited
-
Bramble EnergyFuel cell company on a mission to help the world achieve net zero Frontiers StrategyGrowth
-
Carbon ReClimate tech startup utilising AI to achieve operational efficiency in energy intensive industries Frontiers StrategyEarly Stage
-
Echopoint MedicalTransforming interventional cardiology with optical-fibre based sensors Frontiers StrategyGrowth
-
EpilepsyGTxBiotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy Frontiers StrategyEarly Stage
-
EpsilogenImmuno-oncology company targeting cancer with the IgE class of antibodies Frontiers StrategyEarly Stage
-
FreelineBiopharmaceutical company focused on the development of liver-directed gene therapies Frontiers StrategyIPO
-
GaussionRevolutionising batteries through magneto-electrochemistry: MagLiB technology. Frontiers StrategyGrowth
-
HazySynthetic data platform Frontiers StrategyExited
-
HumanloopSoftware development company that helps businesses build and test AI applications based on large language models (LLMs) Frontiers StrategyExited
-
IntrinsicDeveloping a new type of all silicon non-volatile memory Frontiers StrategyEarly Stage
-
Meira GTXVertically integrated, clinical stage gene therapy company Frontiers StrategyIPO
-
NovalGenImmuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer Frontiers StrategyEarly Stage
-
Nozzle.aiAI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers Frontiers StrategyExited
-
Odin VisionBuilds a new era of cloud connected endoscopy Frontiers StrategyExited
-
Orchard TherapeuticsBiotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases Frontiers StrategyIPO
-
Oriole NetworksUCL spinout using light to train LLMs a hundred times faster with only a fraction of power Frontiers StrategyGrowth
-
Panangium TherapeuticsBiologic for retinal disease targeting a novel alternative pathway to VEGF Frontiers StrategyEarly Stage
-
PhasecraftUsing disruptive theory to unlock the power of quantum computing Frontiers StrategyGrowth
-
PometrySoftware company simplifying graph analytics for businesses Frontiers StrategyEarly Stage
-
Quell TherapeuticsA clinical stage company transforming lives in immune mediated disease Frontiers StrategyGrowth
-
Stanhope AIAI startup leveraging active inference and the free energy principle to build ‘Agentic AI’ for the real world. Frontiers StrategyEarly Stage
-
Third Space LearningEdTech platform connecting tutors in the developing countries to students in developed economies Frontiers StrategyEarly Stage
